Yi Luo
Fudan University
5 Papers
Yi Luo is an academic researcher from Fudan University. The author has contributed to research in topics: Thyroid cancer & Cancer. The author has an hindex of 2, co-authored 5 publications. Previous affiliations of Yi Luo include Fudan University Shanghai Medical College.
Chat about Author
Papers
Cancer-Associated Fibroblasts Positively Correlate with Dedifferentiation and Aggressiveness of Thyroid Cancer.
Shishuai Wen,Ning Qu,Ben Ma,Xiao Wang,Yi Luo,Weibo Xu,Hongyi Jiang,Yan Zhang,Yu Wang,Qinghai Ji +9 more
TL;DR: Wang et al. as discussed by the authors investigated correlations of cancer-associated fibroblast (CAF) with dedifferentiation and clinicopathological characteristics of thyroid cancer and found that high CAF score showed a significant correlation with the anaplastic phenotype in DDTC and low thyroid differentiation score in PTC.
Clinical, Pathological, and Molecular Characteristics Correlating to the Occurrence of Radioiodine Refractory Differentiated Thyroid Carcinoma: A Systematic Review and Meta-Analysis.
Yi Luo,Yi Luo,Hongyi Jiang,Hongyi Jiang,Weibo Xu,Weibo Xu,Xiao Wang,Xiao Wang,Ben Ma,Ben Ma,Tian Liao,Yu Wang,Yu Wang +12 more
TL;DR: Histological subtype, ETE, BRAFV600E mutation, and TERT promoter mutation could be considered clinicopathological factors and biomarkers that could assist in risk stratification, prognostic prediction, and individual therapy options for RR-DTC.
Identification of Key Functional Gene Signatures Indicative of Dedifferentiation in Papillary Thyroid Cancer.
Weibo Xu,Cui-Wei Li,Ben Ma,Zhongwu Lu,Yuchen Wang,Hongyi Jiang,Yi Luo,Yichen Yang,Xiao Wang,Tian Liao,Qinghai Ji,Yu Wang,Wen-Jun Wei +12 more
TL;DR: Wang et al. as discussed by the authors used weighted gene co-expression network analysis (WGCNA) to identify modules highly related to differentiation, and all differentially expressed genes were grouped by function based on the GSEA and literature reviewing data.
ASO Author Reflections: A Novel Three-lncRNA Signature Predictive of Prognoses of HNSCC Patients.
Hongyi Jiang,Ben Ma,Ben Ma,Weibo Xu,Weibo Xu,Yi Luo,Yi Luo,Zhongwu Lu,Zhongwu Lu,Tian Liao,Tian Liao,Xiao Wang,Xiao Wang,Shishuai Wen,Shishuai Wen,Shuwen Yang,Shuwen Yang,Yu Wang,Yu Wang +18 more
TL;DR: Though the three lncRNAs were observed to be a potent biomarker for prognosis, the related mechanisms in HNSCC have not yet been clarified and it will be intriguing to investigate the biological roles of aberrant molecular pathways caused by these three lNCRNAs in H NSCC.
A Novel Three-lncRNA Signature Predicts the Overall Survival of HNSCC Patients
Hongyi Jiang,Ben Ma,Weibo Xu,Yi Luo,Xiao Wang,Shishuai Wen,Tian Liao,Zhongwu Lu,Shuwen Yang,Yu Wang +9 more
TL;DR: The three-lncRNA signature was identified as a predictor of poor prognoses in HNSCC, which may serve as a potential therapeutic target.